In vitro andpre-clinical in vivo evidence support MDMX/MDM2 as common vulnerabilities across TP53 -wild-type T-cell lymphomas that are targetable with the α-helical p53 stapled peptide ALRN-6924 Meeting Abstract
| Authors: | Koch, R.; Christie, A. L.; Yoshida, N.; Ng, S. Y.; Shigemori, K.; Morrow, S. N.; Van Scoyk, A.; Horwitz, S. M.; Jacobsen, E.; Santiago, S.; Ren, J. G.; Guerlavais, V.; Annis, D. A.; Aivado, M. A.; Weinstock, D. M. |
| Abstract Title: | In vitro andpre-clinical in vivo evidence support MDMX/MDM2 as common vulnerabilities across TP53 -wild-type T-cell lymphomas that are targetable with the α-helical p53 stapled peptide ALRN-6924 |
| Meeting Title: | 59th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 130 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2017 Dec 9-12 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2017-12-07 |
| Language: | English |
| ACCESSION: | WOS:000432419401218 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V130.Suppl_1.571.571 |
| Notes: | Meeting Abstract: 571 -- Title error in publisher's record -- Source: Wos |
